Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?

Aishwarya Pradeep,Sheelakumari Raghavan,Scott A. Przybelski,Gregory M. Preboske,Christopher G. Schwarz,Val J. Lowe,David S. Knopman,Ronald C. Petersen,Clifford R. Jack,Jonathan Graff-Radford,Petrice M. Cogswell,Prashanthi Vemuri
DOI: https://doi.org/10.1186/s13195-024-01525-5
2024-07-11
Alzheimer s Research & Therapy
Abstract:White matter hyperintensities (WMH) are considered hallmark features of cerebral small vessel disease and have recently been linked to Alzheimer's disease (AD) pathology. Their distinct spatial distributions, namely periventricular versus deep WMH, may differ by underlying age-related and pathobiological processes contributing to cognitive decline. We aimed to identify the spatial patterns of WMH using the 4-scale Fazekas visual assessment and explore their differential association with age, vascular health, AD imaging markers, namely amyloid and tau burden, and cognition. Because our study consisted of scans from GE and Siemens scanners with different resolutions, we also investigated inter-scanner reproducibility and combinability of WMH measurements on imaging.
neurosciences,clinical neurology
What problem does this paper attempt to address?